Are patients with psoriasis more likely to develop cardiovascular disease, and what mechanisms might link these two conditions? Do the severity of psoriasis and the agents used to treat this condition factor in to determining a patient's cardiovascular risk? Host Dr. Lee Freedman asks Dr. Joel Gelfand, assistant professor of dermatology and medical director of the clinical studies unit in the department of dermatology at Penn Medicine, to describe what physicians should be aware of with patients who have psoriasis. Should these patients be screened more regularly for cardiovascular disease?
Produced in Cooperation with
